Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Myo-Inositol wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
Top outcomes
Verdict
Probably helps
7 of 12 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (1)
Outcomes where both Chamomile and Myo-Inositol have evidence — compare verdict strength side-by-side.
220-1500mg standardized extract daily (often 1100mg in GAD trials), or 1-4 cups of tea
evening
Standardized extract (1.2% apigenin)
2-4g daily for PCOS; up to 12-18g for anxiety
Divided doses with meals, Morning and evening
Myo-inositol powder
2-8 weeks
2-4 weeks
Acute-2 weeks
Acute
3-6 months
4-6 weeks
2-3 months
Initial use or high doses
Therapeutic efficacy and safety of chamomile for state anxiety, generalized anxiety disorder, insomnia, and sleep quality: A systematic review and meta-analysis of randomized trials and quasi-randomized trials.
Phytotherapy research : PTR (2019) · Meta analysis
Reduced anxiety symptoms versus control
Effects of chamomile (Matricaria chamomilla L.) on sleep: A systematic review and meta-analysis of clinical trials.
Complementary therapies in medicine (2024) · Meta analysis
Improved subjective sleep quality
Medicinal herbs for the treatment of anxiety: A systematic review and network meta-analysis.
Pharmacological research (2022) · Meta analysis
Chamomile was not significantly different from placebo for anxiety (MD 0.54, 95% CrI -5.13 to 6.25)
Antenatal dietary supplementation with myo-inositol for preventing gestational diabetes
The Cochrane database of systematic reviews (2023) · Meta analysis · n=1319
For the primary neonatal outcomes, only one study measured the risk of a large-for-gestational-age infant and found myo-inositol was associated with both appreciable benefit and harm (RR 1.40, 95% CI 0.65 to 3.02; 1 study, 234 infants; low-certainty evidence).
Inositol Nutritional Supplementation for the Prevention of Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Nutrients (2022) · Meta analysis · n=1321
Pooled results were expressed as relative risk (RR) or mean difference (MD) with a 95% confidence interval (95% CI).
Short period-administration of myo-inositol and metformin on hormonal and glycolipid profiles in patients with polycystic ovary syndrome: a systematic review and updated meta-analysis of randomized controlled trials
European review for medical and pharmacological sciences (2022) · Meta analysis · n=612
Compared with metformin, the suitable supplemental dosage of myo-ins may be helpful in lowering levels of TG and avoiding adverse events (AEs).
Based on multiple meta-analyses showing improved menstrual regularity and ovulation in PCOS. Evidence quality varies across studies with some showing minimal differences vs placebo. 4g daily most commonly studied dose.
AI-estimated from published studies. Interpret as directional guidance.
Myo-Inositol has a higher evidence score (7/10 vs 5.2/10) and wins in 2 of 3 categories.
For support mood, Myo-Inositol has a higher relevance score (90 vs 50).
No known interactions between Chamomile and Myo-Inositol have been documented in our database. However, always consult a healthcare provider before combining supplements.